What is Single-Cell Interaction Cytometry (scIC)?
Single-cell interaction cytometry (scIC) is a cell-based method for measuring binding kinetics directly on intact living or fixed cells under near-physiological conditions. It delivers real-time kinetic parameters — kon, koff, KD, and avidity — without requiring target purification or surface immobilization. The approach preserves the native membrane environment throughout the measurement, making it relevant for a wide range of targets that are difficult or impossible to study with conventional biophysical platforms.
Key facts
- Platform: heliXcyto (optical detection + microfluidics)
- Output: kon, koff, KD, avidity, single-cell binding curves
- Cell types supported: Cell lines, primary cells, patient-derived material, engineered models
- Target class: Membrane proteins in native lipid environment (GPCRs, transporters, ion channels, cell-surface receptors)
- Analytes: Fluorescently labelled antibodies, bispecifics, multivalent modalities
- Relevant for: Antibody discovery, drug discovery, target validation, cell and gene therapy research
What is single-cell interaction cytometry?
Single-cell interaction cytometry characterizes molecular binding on individual cells rather than averaged populations. Cells are immobilized in microfluidic traps without chemical modification and exposed to fluorescently labelled analytes. The heliXcyto platform then records full association and dissociation curves at the single-cell level in real time.
The result is a kinetic profile — not just an affinity value — resolved per cell. This distinguishes scIC from flow cytometry-based binding assays, which typically yield endpoint measurements and population averages, and from surface-based platforms like SPR or BLI, which rely on purified, immobilized targets.
How does it work?
Cells are introduced into a microfluidic chip and captured in individual traps. No receptor modification, crosslinking, or membrane extraction is involved. Once immobilized, the analyte — typically a fluorescently labelled antibody or binding molecule — is flowed across the cells.
The optical detection system monitors fluorescence intensity over time, generating an association phase as the analyte binds and a dissociation phase as buffer replaces it. These curves are fitted to extract kon, koff, and KD. Because measurements are taken at the single-cell level, the platform also captures cell-to-cell variability in binding behavior, which is averaged out in bulk assays.
Multiple cell types can be tested in parallel, allowing direct comparison across cell lines, primary cells, and engineered models within the same experiment.
Why is it important in drug discovery and antibody development?
Most biophysical platforms require isolated, purified target protein. For many therapeutically relevant membrane proteins — GPCRs, transporters, ion channels — this is either technically very difficult or introduces significant artefacts through detergent solubilization or reconstitution into artificial membranes.
scIC bypasses purification entirely. Kinetic measurements are made on receptors in their correct folding state, native lipid bilayer, and physiologically relevant density. This matters because receptor conformation, lateral mobility, and clustering all influence how a drug candidate binds — and these properties are not replicable in a reconstituted or surface-captured system.
At the single-cell level, scIC also resolves heterogeneity. For primary immune cells, patient-derived material, or cell and gene therapy applications, understanding variability in binding strength across individual cells is scientifically necessary for meaningful interpretation.
Advantages and limitations
Advantages
- No target purification required; directly applicable to GPCRs, ion channels, transporters
- Native membrane environment preserved; correct folding, density, and mobility maintained
- Full kinetic profiles (kon, koff, KD) rather than endpoint binding data
- Single-cell resolution captures population heterogeneity
- Avidity quantifiable from real-time dissociation behavior
- Compatible with primary cells and patient-derived samples
- Applicable to monovalent antibodies, bispecifics, and multivalent formats
Limitations
- Requires fluorescent labelling of the analyte
- Labelling efficiency and position can influence results
- Throughput is lower than high-content flow cytometry approaches
- Currently suited for cell-surface targets; intracellular targets are not accessible without permeabilization
Typical applications
- Avidity profiling of bispecifics, multivalent antibodies, and ADCs
- Kinetic characterization of GPCRs, transporters, and ion channels without purification
- Antibody ranking based on functional dissociation behavior on native targets
- Developability assessment to identify candidates whose potency depends on target overexpression or clustering
- Primary cell and patient-derived sample analysis in immuno-oncology and cell therapy
- Target validation where cellular context is critical to the biological question
Related terms
- Surface plasmon resonance (SPR)
- Biolayer interferometry (BLI)
- Microscale thermophoresis (MST)
- Avidity
- Binding kinetics
- KD, kon, koff
- GPCR binding assay
- Flow cytometry
- Cell-based assay
- Membrane protein drug discovery
Example from practice
At 2bind, scIC is used to address two specific challenges that arise frequently in antibody and drug discovery projects.
The first is avidity quantification. Because the measurement captures real dissociation behavior from native cell surfaces, slow or biphasic off-kinetics indicative of multivalent engagement are directly visible. This allows separation of true monovalent affinity from avidity-driven stabilization — relevant for developability and for predicting in vivo behavior, particularly for bispecifics and other multivalent formats.
The second is access to hard-to-purify targets. For projects involving GPCRs, ion channels, or other conformationally sensitive membrane proteins, measuring binding kinetics without a purification step removes a significant bottleneck in early-stage characterization.
FAQ
What is single-cell interaction cytometry? scIC is a method that measures binding kinetics — association, dissociation, and affinity — directly on intact cells at the single-cell level, using microfluidics and optical detection.
How is scIC different from SPR or BLI? SPR and BLI require immobilized, purified target protein. scIC works with intact cells, preserving the native membrane environment and enabling measurement of targets that cannot be purified without loss of function or conformation.
What kinetic parameters does scIC deliver? kon, koff, KD, and avidity. Full association and dissociation curves are captured per cell.
What cell types can be measured? Cell lines, primary cells, patient-derived material, and engineered cell models. The platform supports direct comparison across cell types within the same experiment.
Why is scIC relevant for bispecifics and multivalent antibodies? Multivalent binding manifests as slow or biphasic dissociation on native cells. scIC captures this directly, enabling functional avidity quantification that is not possible on purified or surface-immobilized targets.
When should scIC be considered over conventional binding assays? When the target is a membrane protein that is difficult to purify, when avidity behavior needs to be characterized functionally, or when single-cell heterogeneity in binding is scientifically relevant — as is often the case for primary immune cells or patient-derived samples.
Conclusion
Single-cell interaction cytometry addresses a practical gap in biophysical characterization: the need to measure binding kinetics on cell-surface targets under conditions that reflect biological reality. By working directly on intact cells, scIC provides access to targets that are inaccessible to purification-based platforms and delivers kinetic data that reflects the full complexity of membrane-bound receptor interactions. For antibody discovery, drug development, and translational research, it adds a cellular dimension to kinetic analysis that supports more informed candidate selection and better mechanistic understanding.
Author
Cosimo Kropp